US$ 28.94
fda stance on bpc 157 BPC-157: The Real Reason Why It's Not Approved FDA takes coser look at
Description
Healing and recovery peptides BPC-157 demonstrates relatively good stability among therapeutic peptides

[4] Ruenzi M

These limitations arise from the insufficient substitution of photoactive groups on the hyaluronate backbone and the inhibitory effect of oxygen

Note the listed product is a 10 mg total vial (5 mg BPC-157 + 5 mg TB-500), so apply the doubled unit counts from the dosing section

Oligodendrocytes in development, myelin generation and beyond
